Abstract
The data generated by DNA arrays are often described as the molecular “portrait” of a particular physiological / pathological sample. Although the emotional reactions could range from revulsion to adoration when viewing those portraits, as it might be when viewing some contemporary art, array technology has fundamentally changed the way researchers approach many biomedical questions. With its ability to monitor the expression level of tens of thousands genes simultaneously, microarray technology has been able to identify “markers” for complex diseases such as cancer. While massive amounts of work lie ahead to validate those marker genes, many researchers are turning their attentions to the low-density, focused arrays. When incorporated with current knowledge on specific biological pathways, these specially tailored macroarrays may be better fitted for purposes such as diagnosis, drug discovery and validation, and prognostic assessment of clinical treatments.
Keywords: microarray, macroarray, cdna array, focused array, pathway-specific array, apoptosis, cancer, biomarker
Current Pharmaceutical Biotechnology
Title: The Making of a Portrait - Bringing it into Focus
Volume: 4 Issue: 6
Author(s): Zeng X.
Affiliation:
Keywords: microarray, macroarray, cdna array, focused array, pathway-specific array, apoptosis, cancer, biomarker
Abstract: The data generated by DNA arrays are often described as the molecular “portrait” of a particular physiological / pathological sample. Although the emotional reactions could range from revulsion to adoration when viewing those portraits, as it might be when viewing some contemporary art, array technology has fundamentally changed the way researchers approach many biomedical questions. With its ability to monitor the expression level of tens of thousands genes simultaneously, microarray technology has been able to identify “markers” for complex diseases such as cancer. While massive amounts of work lie ahead to validate those marker genes, many researchers are turning their attentions to the low-density, focused arrays. When incorporated with current knowledge on specific biological pathways, these specially tailored macroarrays may be better fitted for purposes such as diagnosis, drug discovery and validation, and prognostic assessment of clinical treatments.
Export Options
About this article
Cite this article as:
X. Zeng, The Making of a Portrait - Bringing it into Focus, Current Pharmaceutical Biotechnology 2003; 4 (6) . https://dx.doi.org/10.2174/1389201033377364
DOI https://dx.doi.org/10.2174/1389201033377364 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modified Envelope Glycoproteins to Retarget Retroviral Vectors
Current Gene Therapy Activation of p53 by Specific Agents in Potential Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications
Current Pharmaceutical Biotechnology Approaches to Minimize Infection Risk in Blood Banking and Transfusion Practice
Infectious Disorders - Drug Targets Cycloxygenase-2 (COX-2) - A Potential Target for Screening of Small Molecules as Radiation Countermeasure Agents: An In Silico Study
Current Computer-Aided Drug Design Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry Drug-Mediated Targeted Disruption of Multiple Protein Activities Through Functional Inhibition of the Hsp90 Chaperone Complex
Current Medicinal Chemistry Synthesis and Anticancer Activity of Phthalimido and Naphthalimido Substituted Dihydropyrimidone Conjugates
Letters in Drug Design & Discovery Molecular Phenotype of CXCL12β 3UTR G801A Polymorphism (rs1801157) Associated to HIV-1 Disease Progression
Current HIV Research Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach
CNS & Neurological Disorders - Drug Targets Novel Beta-Lactam Antibiotics Derivatives: Their New Applications as Gene Reporters, Antitumor Prodrugs and Enzyme Inhibitors
Mini-Reviews in Medicinal Chemistry Sauropus androgynus Leaves for Health Benefits: Hype and the Science
The Natural Products Journal Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Current Cancer Drug Targets The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders
Current Drug Targets New N’-Arylidene-2-[(4-Nitrophenyl)Piperazın-1-yl]Acetohydrazide Derivatives: Synthesis and Anticancer Activity Investigation
Letters in Drug Design & Discovery The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry